BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1920122)

  • 1. Anticonvulsant activity of the low-affinity uncompetitive N-methyl-D- aspartate antagonist (+-)-5-aminocarbonyl-10,11-dihydro-5H- dibenzo[a,d]cyclohepten-5,10-imine (ADCI): comparison with the structural analogs dizocilpine (MK-801) and carbamazepine.
    Rogawski MA; Yamaguchi S; Jones SM; Rice KC; Thurkauf A; Monn JA
    J Pharmacol Exp Ther; 1991 Oct; 259(1):30-7. PubMed ID: 1920122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of the uncompetitive N-methyl-D-aspartate antagonist (+-)-5-aminocarbonyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine (ADCI) with its structural analogs dizocilpine (MK-801) and carbamazepine on ethanol withdrawal seizures.
    Grant KA; Snell LD; Rogawski MA; Thurkauf A; Tabakoff B
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1017-22. PubMed ID: 1545374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticonvulsant efficacy of ADCI (5-aminocarbonyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine) after acute and chronic dosing in mice.
    Rogawski MA; Le DQ; Uyakul D; Pannell LK; Subramaniam S; Yamaguchi S; Kokate TG
    Epilepsia; 1995 Jun; 36(6):566-71. PubMed ID: 7555968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine.
    Löscher W; Hönack D
    J Pharmacol Exp Ther; 1991 Feb; 256(2):432-40. PubMed ID: 1671593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of ADCI against convulsant and locomotor stimulant effects of cocaine: comparison with the structural analogs dizocilpine and carbamazepine.
    Seidleck BK; Thurkauf A; Witkin JM
    Pharmacol Biochem Behav; 1994 Apr; 47(4):839-44. PubMed ID: 8029253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral effects and anticonvulsant efficacies of low-affinity, uncompetitive NMDA antagonists in mice.
    Geter-Douglass B; Witkin JM
    Psychopharmacology (Berl); 1999 Oct; 146(3):280-9. PubMed ID: 10541728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticonvulsant profiles of the potent and orally active GABA uptake inhibitors SK&F 89976-A and SK&F 100330-A and four prototype antiepileptic drugs in mice and rats.
    Swinyard EA; White HS; Wolf HH; Bondinell WE
    Epilepsia; 1991; 32(4):569-77. PubMed ID: 1831122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical evaluation of CHF3381 as a novel antiepileptic agent.
    Villetti G; Bregola G; Bassani F; Bergamaschi M; Rondelli I; Pietra C; Simonato M
    Neuropharmacology; 2001 Jun; 40(7):866-78. PubMed ID: 11378157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dizocilpine-like discriminative stimulus effects of low-affinity uncompetitive NMDA antagonists.
    Grant KA; Colombo G; Grant J; Rogawski MA
    Neuropharmacology; 1996; 35(12):1709-19. PubMed ID: 9076750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the anticonvulsant properties of F-721.
    Swinyard EA; Wolf HH; White HS; Skeen GA; Stark LG; Albertson T; Pong SF; Drust EG
    Epilepsy Res; 1993 May; 15(1):35-45. PubMed ID: 8391982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticonvulsant 1-phenylcycloalkylamines: two analogues with low motor toxicity when orally administered.
    Blake PA; Yamaguchi S; Thurkauf A; Rogawski MA
    Epilepsia; 1992; 33(1):188-94. PubMed ID: 1531130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo.
    Parsons CG; Quack G; Bresink I; Baran L; Przegalinski E; Kostowski W; Krzascik P; Hartmann S; Danysz W
    Neuropharmacology; 1995 Oct; 34(10):1239-58. PubMed ID: 8570022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anticonvulsant SGB-017 (ADCI) blocks voltage-gated sodium channels in rat and human neurons: comparison with carbamazepine.
    Sun L; Lin SS
    Epilepsia; 2000 Mar; 41(3):263-70. PubMed ID: 10714396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NMDA receptor antagonist MK-801 has a dissociative effect on seizure activity of hippocampal-kindled cats.
    Wada Y; Hasegawa H; Nakamura M; Yamaguchi N
    Pharmacol Biochem Behav; 1992 Dec; 43(4):1269-72. PubMed ID: 1475311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the NMDA receptor antagonist MK-801 against amygdaloid-kindled seizures in the rat.
    Young NA; Lewis SJ; Vajda FJ; Beart PM
    Exp Neurol; 1989 Feb; 103(2):199-202. PubMed ID: 2536332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.
    Tricklebank MD; Singh L; Oles RJ; Preston C; Iversen SD
    Eur J Pharmacol; 1989 Aug; 167(1):127-35. PubMed ID: 2550253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioural pharmacology of the non-competitive NMDA antagonists dextrorphan and ADCI: relations between locomotor stimulation, anticataleptic potential and forebrain dopamine metabolism.
    Bubser M; Zadow B; Kronthaler UO; Felsheim U; Rückert NG; Schmidt WJ
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):767-73. PubMed ID: 9205962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy.
    Sato K; Morimoto K; Okamoto M
    Brain Res; 1988 Oct; 463(1):12-20. PubMed ID: 2848606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of LY233053: a structurally novel tetrazole-substituted competitive N-methyl-D-aspartic acid antagonist with a short duration of action.
    Schoepp DD; Ornstein PL; Leander JD; Lodge D; Salhoff CR; Zeman S; Zimmerman DM
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1301-8. PubMed ID: 2148188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticonvulsant and behavioral profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor complex.
    Bristow LJ; Hutson PH; Kulagowski JJ; Leeson PD; Matheson S; Murray F; Rathbone D; Saywell KL; Thorn L; Watt AP; Tricklebank MD
    J Pharmacol Exp Ther; 1996 Nov; 279(2):492-501. PubMed ID: 8930150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.